Weiss Multi-Strategy Advisers’s Vanda Pharmaceuticals VNDA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,000	Closed	-$314K	–	620
2018 Q4	$314K	Buy	+12,000	New	+$282K	0.01%	384
2015 Q3	–	Sell	-15,000	Closed	-$190K	–	497
2015 Q2	$190K	Buy	+15,000	New	+$162K	0.01%	414
2014 Q1	–	Sell	-10,000	Closed	-$124K	–	1133
2013 Q4	$124K	Buy	+10,000	New	+$100K	﹤0.01%	931
2013 Q3	–	Sell	-20,000	Closed	-$162K	–	1011
2013 Q2	$162K	Buy	+20,000	New	+$135K	﹤0.01%	723

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Weiss Multi-Strategy Advisers's VNDA Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 20,000 shares — an estimated $328K sold.

Weiss Multi-Strategy Advisers first reported a position in VNDA in Q2 2013 and held it in 26 quarters. The position peaked at $1.99M in Q4 2018. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

Weiss Multi-Strategy Advisers reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 Vanda Pharmaceuticals shares in Q1 2020, an estimated $328K.
Weiss Multi-Strategy Advisers first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 26 quarters.
Weiss Multi-Strategy Advisers's Vanda Pharmaceuticals position peaked at $1.99M in Q4 2018.
159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.